Peter S. Goedegebuure
- Immunology top 0.2%
- Oncology top 0.5%
- Molecular Biology top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Cancer Research top 5%
- Co-authors
- David C. LinehanTimothy J. EberleinBrian A. BeltHong‐Gu JooWilliam E. GillandersWilliam G. HawkinsUdaya LiyanageTodd T. Moore
- Topics
- Immunotherapy and Immune Responses (56 papers)Immune Cell Function and Interaction (30 papers)Cancer Immunotherapy and Biomarkers (25 papers)
- Cited by
- ImmunologyOncologyMolecular Biology
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologyThe Journal of Immunology
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Peter S. Goedegebuure
96 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Immunology 4.7k
- Oncology 3.7k
- Molecular Biology 1.9k
- Radiology, Nuclear Medicine and Imaging 467
- Cancer Research 408
Countries citing papers authored by Peter S. Goedegebuure
This map shows the geographic impact of Peter S. Goedegebuure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter S. Goedegebuure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter S. Goedegebuure more than expected).
Fields of papers citing papers by Peter S. Goedegebuure
This network shows the impact of papers produced by Peter S. Goedegebuure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter S. Goedegebuure. The network helps show where Peter S. Goedegebuure may publish in the future.
Co-authorship network of co-authors of Peter S. Goedegebuure
This figure shows the co-authorship network connecting the top 25 collaborators of Peter S. Goedegebuure. A scholar is included among the top collaborators of Peter S. Goedegebuure based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter S. Goedegebuure. Peter S. Goedegebuure is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 75 | |
| 2 | 63 | |
| 3 | Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responsesbreakdown → | 759 |
| 4 | 43 | |
| 5 | 91 | |
| 6 | 14 | |
| 7 | 351 | |
| 8 | 51 | |
| 9 | DNA vaccination targeting mesothelin combined with anti-GITR antibody induces rejection of pancreatic adenocarcinoma | 2 |
| 10 | 31 | |
| 11 | 22 | |
| 12 | 55 | |
| 13 | 5 | |
| 14 | 12 | |
| 15 | 26 | |
| 16 | 25 | |
| 17 | 26 | |
| 18 | 97 | |
| 19 | 372 | |
| 20 | 32 |
About Peter S. Goedegebuure
Peter S. Goedegebuure is a scholar working on Immunology, Oncology and Molecular Biology, having authored 96 papers that have together received 6.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (56 papers), Immune Cell Function and Interaction (30 papers) and Cancer Immunotherapy and Biomarkers (25 papers). The work is most often cited by research in Immunology (4.7k citations), Oncology (3.7k citations) and Molecular Biology (1.9k citations). Peter S. Goedegebuure has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include David C. Linehan, Timothy J. Eberlein, Brian A. Belt, Hong‐Gu Joo, William E. Gillanders, William G. Hawkins, Udaya Liyanage, Todd T. Moore, Yoshiyuki Tanaka and Steven M. Strasberg. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.